Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$547K Sell
1,556
-298
-16% -$106K 0.04% 404
2025
Q4
$609K Sell
1,854
-79
-4% -$25.1K 0.04% 406
2025
Q3
$546K Buy
1,933
+324
+20% +$94K 0.04% 403
2025
Q2
$449K Sell
1,609
-152
-9% -$43.1K 0.04% 439
2025
Q1
$541K Buy
1,761
+70
+4% +$20.7K 0.05% 357
2024
Q4
$439K Buy
1,691
+268
+19% +$79.5K 0.04% 412
2024
Q3
$459K Sell
1,423
-210
-13% -$68.7K 0.05% 345
2024
Q2
$510K Buy
1,633
+364
+29% +$107K 0.08% 217
2024
Q1
$361K Sell
1,269
-97
-7% -$28.4K 0.06% 270
2023
Q4
$393K Buy
1,366
+187
+16% +$51K 0.05% 323
2023
Q3
$317K Sell
1,179
-3,542
-75% -$884K 0.07% 218
2023
Q2
$1.05M Buy
4,721
+3,343
+243% +$776K 0.17% 123
2023
Q1
$333K Buy
1,378
+74
+6% +$18.2K 0.05% 259
2022
Q4
$342K Buy
1,304
+125
+11% +$33.5K 0.06% 213
2022
Q3
$317K Sell
1,179
-407
-26% -$98.7K 0.07% 218
2022
Q2
$393K Buy
1,586
+423
+36% +$104K 0.09% 156
2022
Q1
$294K Buy
+1,163
New +$267K 0.06% 236

Other funds holding AMGN

Silver Oak Securities's AMGN Position: Q1 2026 in Review

Silver Oak Securities reduced its Amgen (AMGN) stake by 16% in Q1 2026, selling an estimated $106K and leaving 1,556 shares worth $547K. The position accounts for 0.04% of the portfolio, ranked #404.

Silver Oak Securities first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.05M in Q2 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Silver Oak Securities held 1,556 shares of Amgen worth $547K as of Q1 2026.
  • Silver Oak Securities sold 298 Amgen shares in Q1 2026, an estimated $106K.
  • Amgen made up 0.04% of Silver Oak Securities's portfolio in Q1 2026, its #404 holding.
  • Silver Oak Securities first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • Silver Oak Securities's Amgen position peaked at $1.05M in Q2 2023.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Silver Oak Securities's 13F filing for Q1 2026, filed 20 Apr 2026.